Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Clinical trial NCT06065670 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06065670
Sponsor: University of California, San Francisco
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Demyelinating Diseases Demyelination; Corpus Callosum Multiple Sclerosis Brain Lesion Multiple Sclerosis Acute and Progressive Clinically Isolated Syndrome, CNS Demyelinating

Start date: 2026-09-15
Primary completion: 2028-10-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.